Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases
Acquiring Company
AbbVie Inc.
Acquired Company
Landos Biopharma, Inc.
North ChicagoBlacksburgManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
AbbVie Inc. (NYSE: ABBV) (“AbbVie”) and Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos”) today announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for patients with autoimmune diseases. Landos’ lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family) with a bimodal mechanism of action (MOA), which is anti-inflammatory and facilitates epithelial repair.
Quick answer
AbbVie Inc. is acquiring Landos Biopharma, Inc., announced March 25, 2024. AbbVie Inc. is based in North Chicago, Illinois, United States.
- Who acquired Landos Biopharma, Inc?
- AbbVie Inc. agreed to acquire Landos Biopharma, Inc. on March 25, 2024.
- How much did AbbVie Inc. pay for Landos Biopharma, Inc?
- The deal value was not disclosed.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and Landos Biopharma, Inc. based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. Landos Biopharma, Inc. is based in Blacksburg, Virginia, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise (April 30, 2024)
- Future Pak proposes acquisition of Vanda Pharmaceuticals for $7.25 to $7.75 per share in cash (April 17, 2024)
- ONO completes acquisition of Deciphera Pharmaceuticals to reinforce its oncology portfolio (April 30, 2024)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Landos Biopharma, Inc.?
Landos Biopharma, Inc. was acquired by AbbVie Inc., based in North Chicago. The deal was reported on March 25, 2024. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire Landos Biopharma, Inc.?
AbbVie Inc.'s acquisition of Landos Biopharma, Inc. was reported on March 25, 2024. AbbVie Inc. (NYSE: ABBV) (“AbbVie”) and Landos Biopharma, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Landos Biopharma, Inc. do?
Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. It is privately held, operating in Biotechnology, and is based in Blacksburg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.